HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
Outro
Closing notes: FDA update on imlunestrant approval, conflict‑of‑interest statement, and thanks from Neil Love.
Play episode from 57:42
Transcript
